Head-to-head · Cost-Efficiency Index
Neuvé Health vs Elara Health and Wellness
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Neuvé Health
Readers who want the route and the base chosen explicitly and will ask what the monthly figure covers before enrolling.
Visit Neuvé HealthElara Health and Wellness
Shoppers who want labs, physician visits, and coaching bundled into the medication price with no separate membership fee.
Visit Elara Health and WellnessThe verdict
Neuvé Health takes it, leading the Cost-Efficiency Index 68 to 67. Neuvé Health prices twelve GLP-1 products openly — injectable and sublingual, standard and low dose, with a B12 or a glycine base — and then says three different things about whether the medication is inside the monthly figure. Elara Health and Wellness still earns a C — Shoppers who want labs, physician visits, and coaching bundled into the medication price with no separate membership fee.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Neuvé Health.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Neuvé Health | Elara Health and Wellness |
|---|---|---|
| Cost-Efficiency Index | 68/100 | 67/100 |
| Semaglutide / mo | $217/month (standard injectable with B12; the site gives three different answers on whether the medication is inside the figure) | $183/mo (starting dose, yearly plan, plus a separate fee, compounded) |
| Tirzepatide / mo | $324/month (standard injectable with B12; same unresolved question about what the figure covers) | $268/mo (starting dose, bundle, compounded) |
| Semaglutide / yr (modeled) | $2,604 | $2,196 |
| Tirzepatide / yr (modeled) | $3,888 | $3,216 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #127 | #133 |
Neuvé Health
68/100Where the value is
- Prices twelve distinct GLP-1 products before any account: injectable and sublingual, standard and low dose, with a B12 or a B12-free glycine base for each
- States the 503A and 503B compounding classes on the homepage and the About page, which the August record did not find
- Names its founder as a nurse practitioner with a care role rather than referring only to an anonymous network
The tradeoffs
- Three surfaces disagree on whether the medication is inside the monthly price: the weight-loss page is headed "All-in monthly pricing" and lists the compounded drug as included, while its own fine print and the financial policy say medication, labs and supplies are billed separately
- The clinical partner that would settle that question — and that bills for the medication, the labs and the consultation — is never named
Elara Health and Wellness
67/100Where the value is
- Corporate parent (JTE Medical, LLC) and medical director (Jonah Mink, MD, Openloop Healthcare Partners PC) are both publicly named — rare transparency for this market
- Four named 503A pharmacy partners with no ambiguity about who compounds the medication
- Bundled care model: quarterly labs, physician visits, and coaching included in the listed price, no separate membership fee
The tradeoffs
- The annual plan's advertised 'save $792/year' (sema) and 'save $858/year' (tirz) claims do not reconcile against the page's own monthly and annual figures — the discount being marketed isn't visible in the numbers actually published
- Oral semaglutide costs more than the injectable ($208 vs $183/mo) with no explanation offered
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.